Your browser doesn't support javascript.
loading
Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in D-galactosamine-treated rats.
Li, Yating; Lv, Longxian; Ye, Jianzhong; Fang, Daiqiong; Shi, Ding; Wu, Wenrui; Wang, Qing; Wu, Jingjing; Yang, Liya; Bian, Xiaoyuan; Jiang, Xianwan; Jiang, Huiyong; Yan, Ren; Peng, Conggao; Li, Lanjuan.
Afiliação
  • Li Y; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Lv L; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Ye J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Fang D; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Shi D; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Wu W; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Wang Q; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Wu J; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Yang L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Bian X; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Jiang X; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Jiang H; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Yan R; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
  • Peng C; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Li L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Qingchun Road 79, Hangzhou, 31003, People's Republic of China.
Appl Microbiol Biotechnol ; 103(1): 375-393, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30345482

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 3_zoonosis / 4_hepatitis / 6_digestive_diseases Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Microbioma Gastrointestinal / Bifidobacterium adolescentis / Intestinos Tipo de estudo: Etiology_studies Limite: Animals / Humans / Male Idioma: En Revista: Appl Microbiol Biotechnol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 3_zoonosis / 4_hepatitis / 6_digestive_diseases Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Microbioma Gastrointestinal / Bifidobacterium adolescentis / Intestinos Tipo de estudo: Etiology_studies Limite: Animals / Humans / Male Idioma: En Revista: Appl Microbiol Biotechnol Ano de publicação: 2019 Tipo de documento: Article
...